US 9957329
Factor XII inhibitors for the treatment of neurological inflammatory disorders
granted A61KA61K2039/505A61K38/06
Quick answer
US patent 9957329 (Factor XII inhibitors for the treatment of neurological inflammatory disorders) held by Julius-Maximilians-Universitat Wurzburg expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Julius-Maximilians-Universitat Wurzburg
- Grant date
- Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K38/06, A61K38/16, A61K38/1774